Changes of the serum carbohydrate antigen 125 and matrix metalloproteinase levels of patients with adenomyosis after the high intensity focused ultrasound (HIFU) combined with gonadotropin releasing hormone agonist treatment and their correlation with the dysmenorrhea severity of the patients